Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 17Other hematologic neoplasm 12Plasma cell 10Thoracic 7Genitourinary 6Gastrointestinal 5Tumor-Agnostic 4Myeloid 4Gynecologic 4Breast 4Head & Neck 3Other 2Sarcoma 1Other solid neoplasm 1Dermatologic 1CNS 1

Conditions

Mastocytosis, Cutaneous 1

Interventions

pembrolizumab 326Nivolumab 289Ipilimumab 260Cyclophosphamide 194aldesleukin 145Interleukin-2 109fludarabine phosphate 107Temozolomide 83fludarabine 81Dacarbazine 81Radiotherapy 74trametinib 73Vemurafenib 69dabrafenib 66Biopsy 65sargramostim 50Bevacizumab 50Radiosurgery 49Paclitaxel 49Peripheral Blood Stem Cell Transplantation 48Magnetic Resonance Spectroscopy 48Carboplatin 48Imiquimod 47Aminolevulinic Acid 47binimetinib 45Cisplatin 45CTLA-4 Antigen 43cemiplimab 42atezolizumab 41Specimen Handling 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Diphenhydramine × Dermatologic × Clear all
NCT04846348 2024-04-25

Topical Composition Therapy for the Treatment of Cutaneous Mastocytosis

Mayo Clinic

Phase 2 Terminated
1 enrolled 7 charts
DermatologicMyeloid

Mastocytosis, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡